Acevector IPO Day 3: GMP ₹2
Alright folks, we’re halfway through the Acevector IPO subscription period, and it’s Day 3. As of today, September 27th, 2026, the subscription numbers are still showing zero across all categories – Retail, NII, and QIB. That’s right, 0x for everyone. This is certainly a peculiar situation, and we’ll delve into what it might mean for potential investors. The issue price for Acevector is set at ₹32 per share, with a lot size of 468 shares. The IPO is open from September 25th to September 29th, and the expected listing price is hovering around ₹34, based on the current Grey Market Premium (GMP).
| Date | GMP | Est. Listing |
|---|---|---|
| 25 Sep | +₹2 | ₹34 |
Subscription Status
The complete lack of subscription across all investor categories on Day 3 is quite unusual, to say the least. Typically, by this stage, we’d expect to see at least some initial interest, especially from retail investors. A zero subscription for Retail, High Net Worth Individuals (HNIs) or Non-Institutional Investors (NIIs), and Qualified Institutional Buyers (QIBs) could indicate several things. It might mean that investors are waiting for more data, perhaps to see if there’s a surge in applications on the final day. It could also suggest a cautious approach, with many waiting for the sentiment to build. For QIBs, a lack of subscription by Day 3 is generally a red flag, as they are usually the first to show interest if they find the company fundamentally strong. The NII category, often driven by HNIs, also remains untouched. This is where we’d expect to see significant interest if there’s strong demand. The bottom line? The market is currently silent on Acevector, and this silence is deafening.
| Category | Subscription | Progress |
|---|---|---|
| Retail | 4.83x | |
| NII / HNI | 8.53x | |
| QIB | 3.42x | |
| Total | 8.53x |
GMP Update
Now, let’s talk about the Grey Market Premium (GMP). The current GMP for Acevector IPO stands at ₹2. Interestingly, this is unchanged from yesterday’s ₹2. The GMP has remained stable, indicating that the market sentiment in the unofficial grey market hasn’t shifted significantly. An expected listing price of ₹34 (issue price of ₹32 + ₹2 GMP) suggests a modest gain of around 6.25% on listing day. While a positive GMP is always encouraging, a ₹2 premium isn’t exactly setting the market on fire. It suggests a relatively subdued demand and perhaps a wait-and-watch approach from even those participating in the grey market. We’ll need to see if this GMP sees any upward movement in the coming days, especially as the subscription closes.
Should You Apply?
This is the million-dollar question, isn’t it? Based on the current data, it’s a tough call. On one hand, the zero subscription numbers are a significant concern. It’s highly unusual for an IPO to have absolutely no takers by Day 3. This could be a sign of weak investor interest or perhaps a strategic waiting game. On the other hand, the GMP, though modest at ₹2, is positive, suggesting a potential listing gain. However, a ₹2 GMP won’t be enough for many investors looking for substantial returns. It’s also important to remember that the SEBI advisor for IPOs often suggests looking at the company’s fundamentals, future prospects, and the overall market sentiment, not just GMP. Given the current subscription status, a conservative approach might be warranted. Investors might want to wait until the last day to see if there’s a last-minute rush or if the sentiment remains lukewarm. Always do your own due diligence and consider consulting with a SEBI-registered financial advisor before making any investment decisions. View Full Acevector IPO Details here.